The Brazilian Competition Authority recommends conditional clearance of the acquisition transaction between two pharmaceutical companies (Pague Menos / Extrafarma)

Competition Authority (CADE), Brazilian

Previous article The Australian Competition Authority outlines competition concerns in relation to the proposed acquisition between two rail companies (Aurizon / One Rail) Next article The US FTC seeks to block another two hospital mergers following recent successes and growing concerns over increased concentration in the hospitals sector (HCA Healthcare / Steward Health Care System) (RWJ Barnabas Health / Saint Peter’s Healthcare System)

9 Jun 2022

The Brazilian Competition Authority recommends conditional clearance of the acquisition transaction between two pharmaceutical companies (Pague Menos / Extrafarma)

KEYWORDS

Reference

Brazilian Competition Authority, Pague Menos / Extrafarma, Press release, 9 June 2022

CADE's investigative arm recommends Pague Menos' acquisition of Extrafarma be conditionally cleared* The Tribunal of the agency will review the case for a final decision CADE's investigative body remitted the acquisition of the pharmacy chain Extrafarma

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Author

Brazilian Competition Authority (CADE)
Brazilian Administrative Council for Economic Defense (CADE) (Brasilia)

Brazil 17 contributions 7085 visits

Quotation

Brazilian Competition Authority (CADE), The Brazilian Competition Authority recommends conditional clearance of the acquisition transaction between two pharmaceutical companies (Pague Menos / Extrafarma), 9 June 2022, e-Competitions June 2022 - II, Art. N° 107051

Visites 745